Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 59,961 |
|
|||||
| News | - | ||||||
| Day High | 4.95 | Low High |
|||||
| Day Low | 4.6009 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ProPhase Labs Inc | PRPH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.24 | -4.85% | 4.71 | 16:07:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.95 | 4.6009 | 4.95 | 4.71 | 4.95 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 616 | 59,961 | $ 4.79 | $ 287,265 | - | 4.05 - 9.9412 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:15:17 | 1 | $ 4.65 | USD |
ProPhase Labs Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 84.99M | 18.05M | - | 44.38M | -16.78M | -0.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ProPhase Labs News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRPH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.31 | 5.46 | 4.6009 | 5.11 | 41,011 | -0.60 | -11.30% |
| 1 Month | 6.59 | 7.48 | 4.6009 | 5.83 | 108,157 | -1.88 | -28.53% |
| 3 Months | 5.01 | 7.48 | 4.3734 | 5.61 | 52,869 | -0.30 | -5.99% |
| 6 Months | 4.48 | 7.48 | 4.25 | 5.29 | 38,534 | 0.23 | 5.13% |
| 1 Year | 7.74 | 9.9412 | 4.05 | 6.36 | 47,911 | -3.03 | -39.15% |
| 3 Years | 5.30 | 15.25 | 4.05 | 7.84 | 89,724 | -0.59 | -11.13% |
| 5 Years | 3.00 | 16.04 | 1.37 | 7.27 | 94,566 | 1.71 | 57.00% |
ProPhase Labs Description
| ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services. |
